FDA Authorizes Evusheld Emergency Use to Prevent COVID-19 in Immunocompromised Patients
December 9, 2021
People with lupus can be immunocompromised because of the disease itself or medications that suppress the immune...
AstraZeneca
Lupus Research Alliance Breaking Through Gala Sets New Record, Raising $7.5 Million for Lupus Research
New York, NY. November 23, 2021 – Last night’s Lupus Research Alliance (LRA) Breaking Through Gala was the most successful...
Important Message from CEO Kenneth Farber: U.S. FDA Approves New Lupus Treatment
August 2, 2021
Dear Friend of the Lupus Research Alliance,
As we reported this morning, the lupus community has much to...
Lupus Research Alliance Applauds U.S. FDA Approval of AstraZeneca’s anifrolumab-fnia (Saphnelo™) for Systemic Lupus Erythematosus (SLE)
First in New Class of Drugs in More than a Decade for SLE Targeting Type 1 Interferons
NEW YORK, NY....
LRA Welcomes Positive Results with Anifrolumab for Reducing Lupus Flares
May 13, 2021
A new study analyzing data from two large clinical trials showed that the investigational therapy anifrolumab reduced...
Promising News from Major Medical Meeting, EULAR
Updated June 5, 2020
One of the largest meetings for rheumatologists went virtual this year to enable scientists from around...
LRA Celebrates Major Research Breakthroughs in 2019
January 7, 2020
2019 was a phenomenal, breakthrough year for lupus research on both the clinical development and basic science...
Positive Results on Anifrolumab for Lupus Published in New England Journal of Medicine
December 18, 2019
The Lupus Research Alliance (LRA) welcomes additional positive results published today in the New England Journal of...
Lupus Research Alliance Response to Positive Data from Phase 3 Anifrolumab Trial Presented at 2019 ACR/ARP Annual Meeting
NEW YORK, NY – November 11. The Lupus Research Alliance (LRA) congratulates AstraZeneca on new positive results from the...
MOMENTOUS NEWS — Potential New Lupus Treatment Effectively Reduced Disease Activity in Phase III Trial
NEW YORK, NY. August 29 -- The Lupus Research Alliance is excited to share the good news that a...